Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial

2013202 citationsJournal Articlebronze Open Access

Authors

Renato Martins · Eaton (Taiwan)

Upendra Parvathaneni · Eaton (Taiwan)

Julie E. Bauman · Eaton (Taiwan)

Anand K. Sharma · Eaton (Taiwan)

Luis E. Raez · Eaton (Taiwan)

Michael A. Papagikos · Eaton (Taiwan)

Furhan Yunus · Eaton (Taiwan)

Abstract

Erlotinib did not increase the toxicity of cisplatin and radiotherapy in patients with locally advanced HNSCC but failed to significantly increase CRR or PFS.

Topics & Keywords

Head and Neck Cancer Studies Lung Cancer Treatments and Mutations Colorectal and Anal Carcinomas

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 31, Issue 11, pp. 1415-1421

DOI: 10.1200/jco.2012.46.3299

Field-Weighted Citation Impact: 23.33